Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (2591) Revenue

0 Followers

Statistics Market Cap Revenue

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Revenue

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H had a revenue of 73.81M in the quarter ending Dec 31, 2025, with 21.74%. This bring the company's revenue in the last twelve months to 134.44M, Decreased 121.74%. In the fiscal year ending Dec 31, 2025, Guangzhou Innogen Pharmaceutical Group Co Ltd Class H had annual revenue of 128.11M with Infinity% growth.

Revenue (ttm)

134.44M

Revenue Growth

―

P/S Ratio

50.57

Revenue/Employee

HK$1,220,051

Employees

105

Market Cap

HK$6.48B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	128.11M	―	+∞%
Dec 31, 2024	―	―	―
Dec 31, 2023	―	―	―